UMIN ID: UMIN000055584
Registered date:24/09/2024
The outcome of chemoradiotherapy for NSCLC - EGFR mutant vs wild-type -
Basic Information
Recruitment status | Pending |
---|---|
Health condition(s) or Problem(s) studied | non small cell lung cancer |
Date of first enrollment | 2024/10/01 |
Target sample size | |
Countries of recruitment | Japan |
Study type | Others,meta-analysis etc |
Intervention(s) |
Outcome(s)
Primary Outcome | progression-free survival and overall survival |
---|---|
Secondary Outcome | post-progression survival, patterns of disease progression |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Exclusion criteria were: (i) non-English publications; (ii) studies including patients receiving targeted therapy or immunotherapy; (iii) studies involving radiotherapy alone. |
Related Information
Primary Sponsor | JAPANESE RED CROSS ISE HOSPITAL, Department of Radiation Oncology, Satoru Ochiai |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | JAPANESE RED CROSS ISE HOSPITAL, Department of Radiation Oncology, Satoru Ochiai |
Secondary ID(s) |
Contact
public contact | |
Name | Satoru Ochiai |
Address | Ise Red Cross Hospital 1-471-2 Funae, Ise City, Mie Prefecture, Japan Japan 516-8512 |
Telephone | 0596-28-2171 |
sochiamn@gmail.com | |
Affiliation | JAPANESE RED CROSS ISE HOSPITAL Department of Radiation Oncology |
scientific contact | |
Name | Satoru Ochiai |
Address | Ise Red Cross Hospital 1-471-2 Funae, Ise City, Mie Prefecture, Japan Japan |
Telephone | 0596-28-2171 |
sochiamn@gmail.com | |
Affiliation | JAPANESE RED CROSS ISE HOSPITAL Department of Radiation Oncology |